Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK SILVERMAN

NPI
1780674184
CMS profile
262673
Location
OCEANSIDE, NY

General Payments · PY2018–2024

$2,137.26

  • Reported across 70 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$280.38

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $280.38 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $261.66 14
ABBVIE INC. $18.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $123.23 8
PY2019 $767.38 20
PY2020 $64.85 3
PY2021 $440.94 8
PY2022 $282.98 8
PY2023 $177.50 8
PY2024 $280.38 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.72 10/07/2024 Food and Beverage Undisputed 01/23/2026 1106103691 CMS
Novartis Pharmaceuticals Corporation $3.41 02/26/2024 Food and Beverage Undisputed 01/23/2026 1087270999 CMS
Novartis Pharmaceuticals Corporation $26.01 02/26/2024 Food and Beverage Undisputed 01/23/2026 1087271001 CMS
Novartis Pharmaceuticals Corporation $23.66 04/08/2024 Food and Beverage Undisputed 01/23/2026 1087270993 CMS
Novartis Pharmaceuticals Corporation $4.41 04/08/2024 Food and Beverage Undisputed 01/23/2026 1087270995 CMS
Novartis Pharmaceuticals Corporation $25.33 05/17/2024 Food and Beverage Undisputed 01/23/2026 1087271003 CMS
Novartis Pharmaceuticals Corporation $25.33 06/03/2024 Food and Beverage Undisputed 01/23/2026 1087271005 CMS
Novartis Pharmaceuticals Corporation $4.97 07/22/2024 Food and Beverage Undisputed 01/23/2026 1087271009 CMS
Novartis Pharmaceuticals Corporation $21.97 07/22/2024 Food and Beverage Undisputed 01/23/2026 1087271011 CMS
Novartis Pharmaceuticals Corporation $2.39 09/16/2024 Food and Beverage Undisputed 01/23/2026 1087271015 CMS
Novartis Pharmaceuticals Corporation $23.20 09/16/2024 Food and Beverage Undisputed 01/23/2026 1087271017 CMS
Novartis Pharmaceuticals Corporation $30.40 10/10/2024 Food and Beverage Undisputed 01/23/2026 1087271013 CMS
Novartis Pharmaceuticals Corporation $19.88 11/01/2024 Food and Beverage Undisputed 01/23/2026 1087271023 CMS
Novartis Pharmaceuticals Corporation $28.17 11/25/2024 Food and Beverage Undisputed 01/23/2026 1087271025 CMS
Novartis Pharmaceuticals Corporation $22.53 12/12/2024 Food and Beverage Undisputed 01/23/2026 1087271027 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.